During the last session, ProMIS Neurosciences Inc (NASDAQ:PMN)’s traded shares were 0.11 million, with the beta value of the company hitting 0.06. At the end of the trading day, the stock’s price was $0.63, reflecting an intraday gain of 3.42% or $0.02. The 52-week high for the PMN share is $2.37, that puts it down -276.19 from that peak though still a striking 19.05% gain since the share price plummeted to a 52-week low of $0.51. The company’s market capitalization is $20.76M, and the average intraday trading volume over the past 10 days was 42320.0 shares, and the average trade volume was 39.51K shares over the past three months.

ProMIS Neurosciences Inc (NASDAQ:PMN) trade information

ProMIS Neurosciences Inc (PMN) registered a 3.42% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 3.42% in intraday trading to $0.63, hitting a weekly high. The stock’s 5-day price performance is 14.93%, and it has moved by -7.97% in 30 days. Based on these gigs, the overall price performance for the year is -70.60%. The short interest in ProMIS Neurosciences Inc (NASDAQ:PMN) is 0.18 million shares and it means that shorts have 7.23 day(s) to cover.

While earnings are projected to return -649.27% in 2025.

PMN Dividends

ProMIS Neurosciences Inc is due to release its next quarterly earnings on 2025-Mar-30. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

ProMIS Neurosciences Inc (NASDAQ:PMN)’s Major holders

ProMIS Neurosciences Inc insiders own 27.56% of total outstanding shares while institutional holders control 29.84%, with the float percentage being 41.20%.

Data provided on Feb 28, 2025 indicates that Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund owns about 8.62 shares. This amounts to just over 0.03 percent of the company’s overall shares, with a $5474.0 market value.